Is This a Pharmaceutical Start Up?

martin screlly, a 32 year old financial wiz, i guess you could call him a used to manage ha hedge fund. He left the hedge fund and was part of a pharmosutical company called retro fin. And retrofin acquired the rights to sell a drug called theolais used to treat sistenuria. That's a rare, incurable condition which gives you persistent kidney stones.